Results 241 to 250 of about 61,548 (302)

New selective and allosteric FLT3 inhibitors show efficacy against resistant acute myeloid leukemia cells. [PDF]

open access: yesiScience
Ge SS   +14 more
europepmc   +1 more source

The leverage ratio and liquidity in the gilt and gilt repo markets [PDF]

open access: yesJournal of Financial Markets, 2020
Market participants argue that a significant unintended consequence of post-crisis regulatory leverage ratio requirements is a reduction in the liquidity of fixed income markets. We assess this claim in the context of the gilt (U.K. government bond) and gilt repo markets over the period 2010 to 2017. We find that gilt repo liquidity worsened during the
Bicu-Lieb, Andreea   +2 more
exaly   +4 more sources

Gilt Management for Fertility and Longevity

open access: yesAnimals, 2019
Substantial evidence supports successful management of gilts as an absolutely necessary component of breeding herd management and the pivotal starting point for the future fertility and longevity of the breeding herd. Therefore, gilt management practices
Jennifer Patterson, George Foxcroft
exaly   +2 more sources
Some of the next articles are maybe not open access.

Related searches:

Pharmacokinetics of altrenogest in gilts

Journal of Veterinary Pharmacology and Therapeutics, 2019
AbstractAltrenogest, a synthetic progestogen, is characterized by its estrus synchronization in mares, ewes, sows, and gilts. To investigate the pharmacokinetic profile and evaluate its accumulation in gilts, 18 oral doses of 20 mg altrenogest/gilt/day were given to eight healthy gilts at an interval of 24 hr.
Hongzhi Xiao   +10 more
openaire   +2 more sources

Coccidiosis in replacement gilts

Veterinary Record, 2005
COCCIDIOSIS in pigs is normally associated with fiveto 15day-old sucking pigs. Diarrhoea with up to 20 per cent mortality results, and subsequent growth may be compromised. Isospora suis infection is invariably diagnosed in such cases (Cook 1996, Taylor 1999).
C M, Gaudie, R J, Evans, S H, Done
openaire   +2 more sources

Home - About - Disclaimer - Privacy